Tornincasa, Antonio
 Distribuzione geografica
Continente #
EU - Europa 137
NA - Nord America 54
AS - Asia 37
AF - Africa 2
SA - Sud America 2
Totale 232
Nazione #
IT - Italia 75
US - Stati Uniti d'America 54
GB - Regno Unito 38
SG - Singapore 13
DE - Germania 10
HK - Hong Kong 8
FI - Finlandia 7
CN - Cina 6
LT - Lituania 4
TR - Turchia 4
CZ - Repubblica Ceca 3
ID - Indonesia 3
NG - Nigeria 2
TW - Taiwan 2
AR - Argentina 1
BR - Brasile 1
IL - Israele 1
Totale 232
Città #
Enfield 32
Bologna 30
Ashburn 25
Singapore 12
Milan 10
New York 9
Hong Kong 8
Phoenix 7
Cardiff 6
Helsinki 6
Munich 5
Sassuolo 5
Lüleburgaz 4
Modena 4
Reggio Emilia 4
Brno 3
Frankfurt am Main 3
Jakarta 3
Los Angeles 3
Casalgrande 2
Florence 2
Guangzhou 2
Lagos 2
Padova 2
Sant'Egidio alla Vibrata 2
Taipei 2
Bagnacavallo 1
Dallas 1
Hangzhou 1
Jerusalem 1
Lappeenranta 1
San Jose 1
Shanghai 1
Vinhedo 1
Totale 201
Nome #
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 91
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 50
Adding weekly carboplatin to sequential anthracycline and paclitaxel-based chemotherapy as neoadjuvant treatment for triple negative breast cancer (TNBC) patients: a propensity scorematched study 45
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 25
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (British Journal of Cancer, (2023), 128, 2, (266-274), 10.1038/s41416-022-02050-8) 20
Atezolizumab-Related Sarcoidosis-Like Reaction in Early Breast Cancer Patient: Know It To Diagnose It: A Case Report with Review of the Literature 7
Totale 238
Categoria #
all - tutte 1.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202371 0 0 0 0 0 0 0 0 0 0 71 0
2023/2024140 5 6 9 16 10 14 31 5 6 3 20 15
2024/202527 12 2 13 0 0 0 0 0 0 0 0 0
Totale 238